Polyrizon Ltd., a biotech company focused on intranasal hydrogels, announced significant findings from ex vivo studies that demonstrate the strong mucoadhesion and broad surface coverage of its ...
Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...